Lucid Psycheceuticals
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
243 College St Ste 101, Toronto, Ontario...Website
www.lucidpsycheceuticals.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Lucid Psycheceuticals
Lucid Psycheceuticals, founded in 2020 and based in Canada with multiple locations across North America, is a pharmaceutical company focused on developing novel therapeutics for brain health. The company specializes in creating innovative psycheceutical products rooted in scientific research and protected by strong intellectual property. Lucid Psycheceuticals aims to advance the field of neurological and mental health treatments through their specialized pharmaceutical development programs.Explore more
Lucid Psycheceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lucid Psycheceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Lucid Psycheceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Lucid Psycheceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Lucid Psycheceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Lucid Psycheceuticals launches new products
Funding: Get notified immidiatlly once Lucid Psycheceuticals has new funding data
Check if Lucid Psycheceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Lucid Psycheceuticals
Website visits: Recent activity has been detected on your website
Check out if Lucid Psycheceuticals is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Lucid Psycheceuticals
Compare insights from companies similar to Lucid Psycheceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lucid Psycheceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lucid Psycheceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lucid Psycheceuticals.
Lucid Psycheceuticals Tech Stack
A closer look at the technologies used by Lucid Psycheceuticals
Most Recent Scoops
Event
Events
Executive Move
Mergers & Acquisitions (M&A)
Mergers & Acquisitions (M&A)
Lucid Psycheceuticals News & Media
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium
TORONTO--(BUSINESS WIRE)---- $HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that is wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), filed a provisional patent application on novel formulations of palmitoylethanolamide (PEA). The new patent application is based on the results of completed preclinical animal toxInvestmentPitch Media Video Discusses FSD Pharma's Closing of its acquisition of Canadian Specialty Psychedelic Pharmaceutical Company Lucid Psycheceuticals - Video Available on Investmentpitch.com
Vancouver, British Columbia--(Newsfile Corp. - September 22, 2021) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions in legal psychedelics and medical cannabis, has closed its acquisition of Lucid Psycheceuticals. Founded in 2020, Lucid Psycheceuticals (www.LucidPsycheceuticals.com), a Canadian-based specialty psychedelic pharmaceutical company, is developing novel molecules and combinationsFSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition
TORONTO--(BUSINESS WIRE)---- $HUGE #RestoreFSD--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is pleased to announce the completion of the previously announced acquisition of 100% of the issued and outstanding shares of Lucid Psycheceuticals Inc. (“Lucid”), a Canadian-based specialty psychedelic pharmaceutical company focused on the development of therapies
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Lucid Psycheceuticals
Sign Up For FreeTo access detailed company insights
Lucid Psycheceuticals, founded in 2020 and based in Canada with multiple locations across North America, is a pharmaceutical company focused on developing novel therapeutics for brain health. The company specializes in creating innovative psycheceutical products rooted in scientific research and protected by strong intellectual property. Lucid Psyc... Read More
